MAVS and infection: For example, during influenza A virus (IAV) or vesicular stomatitis virus (VSV) infections, MARCHF5 can target and ubiquitinate MAVS aggregates to suppress MAVS-mediated type I IFN signaling and excessive immunopathology (13).